News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And U.S.-Based Merck & Co., Inc. (MRK) To Collaborate On Companion Diagnostic Test For Analysis Of Tumor PD-L1 Levels



5/30/2014 8:09:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GLOSTRUP, Denmark, May 30, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced a collaboration with Merck & Co., Inc. ( known as MSD outside the United States and Canada, through an affiliate) to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the treatment of cancer.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES